Rhus (toxicodendron) dermatitis

Primary Care - Clinics in Office Practice

Volumn 27, Issue 2, 2000, Pages 493-502

  Tanner, Tina L ^b  

^a Saginaw Cooperative Hospitals Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; URUSHIOL;

CELLULAR IMMUNITY; CROSS REACTION; HUMAN; PAPULAR SKIN DISEASE; POISON IVY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; SKIN ALLERGY;

EID: 0034083474     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70209-8     Document Type: Article

References (23)

1. R.L. Baer Poison ivy dermatitis Cutis 46 1990 34 36
2. K.D. Boehm J.K. Yun K.P. Strohl In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiol Exp Dermatol 5 1996 150 160
3. C. Dannaker H.I. Maibach Poison ivy and poison oak dermatitis C.R. Lovell Plants and the Skin ed 1 1993 Blackwell Scientific Publications, Inc. Cambridge, MA 105 121
4. W.L. Epstein Occupational poison ivy and oak dermatitis Dermatol Clin 12 1994 511 516
5. W.L. Epstein Topical prevention of poison ivy/oak dermatitis Arch Dermatol 125 1989 499 501
6. W.L. Epstein The poison ivy picker of Pennypack Park: The continuing saga of poison ivy J Invest Dermatol 88 3 Suppl 1987 7 11
7. A.A. Fisher Poison ivy/oak dermatitis Part I: Prevention—soap and water, topical barriers, hyposensitization 57 1996 384 386
8. A.A. Fisher Poison ivy/oak/sumac. Part II: Specific features Cutis 58 1996 22 24
9. C. Gelber L. Gemmell D. McAteer Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide: Hapten conjugate J Immunol 158 1997 2425 2434
10. M. Geller Poison ivy, mangoes, cashews, and dermatitis Ann Intern Med 110 1989 1036 1037
11. G.A. Gellin C.R. Wolf T.H. Milby Poison ivy, poison oak, and poison sumac. Common causes of occupational dermatitis Arch Environ Health 22 1971 280 286
12. S.A. Grevelink D.F. Murrell E.A. Olsen Effectiveness of various barrier preparations in preventing and/or amelioration experimentally produced Toxicodendron dermatitis J Am Acad Dermatol 27 1992 182 188
13. C.E. Griffiths J.N. Barker S. Kunkel Modulation of leukocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis) Br J Dermatol 124 1991 519 526
14. G. Juckett Plant dermatitis: Possible culprits go far beyond poison ivy Postgrad Med 100 1996 3
15. A. Kecskes P. John H. Wendt Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers Eur J Clin Pharmacol 43 1992 157 159
16. J.G. Marks J.F. Fowler E.F. Sherertz Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite J Am Acad Dermatol 33 1995 212 216
17. E.C. McGuffey What methods are effective to prevent or treat poison ivy/oak/sumac? Am Pharm 33 1993 18
18. G. Quick Scratching below the surface of poison ivy rash Consultant 35 1995 545
19. M. Rademaker M.B. Duffill Allergic contact dermatitis to Toxicodendron succedaneum (rhus tree): An autumn epidemic N Z Med J 108 1995 121 123
20. R.L. Rietschel A pilot study of pentoxifylline for the prevention of poison ivy/oak reactions Contact Dermatitis 32 1995 365 366
21. R.F. Reginella J.C. Fairfield J.G. Marks Hyposensitization to poison ivy after working in a cashew nut shell oil processing factory Contact Dermatitis 20 1989 274 279
22. P.M. Williford E.F. Sherertz Poison ivy dermatitis. Nuances in treatment Arch Fam Med. 3 1994 184 188
23. W.E. Wooldridge Acute allergic contact dermatitis: How to manage severe cases Postgrad Med 87 1990 4